{"accession":"BGC0000219","version":4,"changelog":{"releases":[{"version":"1","entries":[{"contributors":["IROSGRAECON7XFWB774QFHDN"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2015-06-12","comment":"Submitted"}],"date":"2015-06-12"},{"version":"2","entries":[{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2019-10-16","comment":"Migrated from v1.4"}],"date":"2019-10-16"},{"version":"3","entries":[{"contributors":["AAAAAAAAAAAAAAAAAAAAAAAA"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2022-10-07","comment":"Update chemical activity to schema version 2.11"}],"date":"2022-10-07"}]},"quality":"questionable","status":"active","completeness":"complete","loci":[{"accession":"AM900040.1","location":{"from":0,"to":0},"evidence":[{"method":"Knock-out studies"},{"method":"Heterologous expression"}]}],"biosynthesis":{"classes":[{"class":"PKS","subclass":"Type II","cyclases":[]},{"class":"saccharide","glycosyltransferases":[],"subclass":"hybrid/tailoring"}]},"compounds":[{"name":"elloramycin","evidence":[],"bioactivities":[{"name":{"activity":"cytotoxic"},"observed":true,"references":[]}],"structure":"C[C@H]1[C@H]([C@@H]([C@H](O[C@@H]1OC2=CC3=CC4=C(C(=C3C(=C2C(=O)OC)C)O)C(=O)[C@@]5(C(=O)C=C([C@H]([C@@]5(C4=O)O)O)OC)OC)OC)OC)OC","mass":660.2054204519999,"formula":"C32H36O15"}],"taxonomy":{"name":"Streptomyces olivaceus","ncbiTaxId":47716},"genes":{"annotations":[{"id":"CAP12606.1","name":"elmMI"},{"id":"CAP12609.1","name":"elmMIII"},{"id":"CAP12608.1","name":"elmMII"}]},"comment":"Elloramycin is a hybrid compound comprising a tetracenomycin scaffold and a sugar moiety. A second genomic loci comprises the Rha cluster - accession number: AM889123, Responsible for saccharide biosynthesis. Biosynthesis is discussed in PubMed ID: 18310024.","legacy_references":["pubmed:18310024"]}